한글목차

'셀 소터 시장은 셀 소터의 진보, 의료와 연구에서 셀 소터의 채택 증가에 의해 2023-2032년 8.6%의 대폭적인 성장률을 경험할 가능성이 높은 '-Allied Market Research의 최신 리포트 '셀 소터 시장'에 따르면 셀 소터 시장은 2022년에 5억 달러로 평가되며, 2023-2032년 CAGR 8.6%로 성장하며, 2032년에는 13억 달러에 달할 것으로 예측되고 있습니다.

세포 선별은 물리적 또는 생물학적 특성에 따라 시료에서 특정 세포 유형을 분리하는 절차입니다. 이러한 특성에는 크기, 형태, 생존율, 세포 내/외부 단백질 발현 등이 포함됩니다. 세포 선별을 통해 연구, 진단, 치료 등 다양한 목적으로 사용되는 균질한 세포 집단을 얻을 수 있습니다.

셀 분류기 시장은 분류 속도 향상, 감도와 정확도 향상, 다양한 시료량 처리 능력 등 지속적인 기술 발전으로 인해 성장세를 보이고 있습니다. 이러한 발전으로 셀 분류기는 더욱 효율적이고 사용하기 쉬워졌으며, 다양한 연구 요구 사항을 충족할 수 있게 되었습니다. 또한 암, 자가면역질환, 감염성 질환과 같은 만성질환의 발생률이 증가함에 따라 질병 메커니즘을 이해하고 효과적인 치료법을 개발하기 위한 첨단 연구 툴이 필요하게 되었습니다. 세포 분류기는 상세한 세포 분석을 용이하게 하고, 새로운 치료 표적과 진단 바이오마커를 발견하는 데 도움이 되기 때문에 시장 성장에 기여하고 있습니다.

희귀 세포 집단 연구, 질병 기전 규명, 개인 맞춤형 의료 접근법 모색 등 세포 생물학 연구의 끊임없는 발전은 세포 분류 기술에 대한 수요를 창출하고 시장 성장을 가속하고 있습니다. 세포 분류기는 연구자들이 추가 분석 및 실험을 위해 특정 세포 유형 및 하위 집단을 분리할 수 있게 해줍니다. 또한 정부, 민간 단체 및 자금 지원 기관은 세포 생물학 및 면역학을 포함한 생명과학 연구에 대한 투자를 늘리고 있습니다. 이러한 자금 지원은 세포 분류기를 포함한 첨단 연구 툴의 개발 및 채택을 지원하여 시장 개척의 원동력이 되고 있습니다. 그러나 신흥 국가에서는 셀 분류기 장비의 높은 비용과 숙련된 전문가 부족으로 인해 셀 분류기 도입이 제한되어 시장 성장이 제한되고 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

• 시장의 정의와 범위
• 주요 조사 결과
  • 영향요인
  • 주요 투자 기회
• Porter's Five Forces 분석
• 시장 역학
  • 촉진요인
    • 셀 소터의 기술적 진보의 증가
    • 연구개발 활동에 대한 정부 지원의 급증
    • HIV와 암의 유병률 증가
  • 억제요인
    • 셀 소터의 고비용
  • 기회
    • 신흥 시장에서 성장 기회

제4장 셀 소터 시장 : 제품별

• 개요
• 기기형
  • 기기형 셀 소터 시장 : 유형별
• 소모품·시약

제5장 셀 소터 시장 : 용도별

• 개요
• 연구 용도용
  • 연구 용도용 셀 소터 시장 : 유형별
• 임상 용도용

제6장 셀 소터 시장 : 최종사용자별

• 개요
• 병원 및 임상 검사 연구소
• 제약·바이오테크놀러지 기업
• 기타

제7장 셀 소터 시장 셀 소터 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 일본
  • 중국
  • 호주
  • 인도
  • 한국
  • 기타
• 라틴아메리카·중동 및 아프리카
  • 브라질
  • 사우디아라비아
  • 남아프리카공화국
  • 기타

제8장 경쟁 상황

• 서론
• 주요 성공 전략
• 주요 10 기업의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝, 2022년

제9장 기업 개요

• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Cytonome/St, LLC
• Danaher Corporation
• Harvard Bioscience, Inc.
• Miltenyi Biotec GmbH
• On-Chip Biotechnologies Co., Ltd.
• Thermo Fisher Scientific Inc.
• Sony Corporation
• Sysmex Corporation

영문목차

"The Cell Sorter Market is likely to experience a significant growth rate of 8.6% from 2023-2032 owing to advancement in cell sorters and rise in adoption of cell sorters in healthcare and research" - Allied Market Research. According to a new report published by Allied Market Research, titled, "Cell Sorter Market," The cell sorter market was valued at $0.5 billion in 2022, and is estimated to reach $1.3 billion by 2032, growing at a CAGR of 8.6% from 2023 to 2032. Cell sorting is a procedure that involves the separation of a specific cell type from a sample on the basis of its physical or biological characteristics. These characteristics may include size, morphology, viability, and the expression of proteins both inside and outside the cell. By performing cell sorting, a homogeneous population of cells is obtained, which are utilized for various purposes such as research, diagnosis, and therapy.

The cell sorter market is driven by factors that include continuous technological advancements, such as improvements in sorting speed, increased sensitivity & accuracy, and the ability to handle a wide range of sample volumes. These advancements make cell sorters more efficient, user-friendly, and capable of handling diverse research requirements. In addition, the rise in incidence of chronic diseases, such as cancer, autoimmune disorders, and infectious diseases, creates a need for advanced research tools to understand disease mechanisms and develop effective treatments. Cell sorters facilitate in-depth cellular analysis, aiding in the discovery of novel therapeutic targets and diagnostic biomarkers, which support market growth.

The continuous advancements in cell biology research, such as studying rare cell population, understanding disease mechanisms, and exploring personalized medicine approaches, create a demand for cell sorting technologies and propels market growth. Cell sorters enable researchers to isolate specific cell types or subpopulation for further analysis and experimentation. Moreover, governments, private organizations, and funding agencies are increasingly investing in life sciences research, including cell biology and immunology. This funding supports the development and adoption of advanced research tools, including cell sorters, and drives market growth. However, the high cost of cell sorter instruments and lack of skilled professionals in developing countries limit the adoption of cell sorter and restrain market growth.

The cell sorter market is segmented into product, application, end user, and region. By product, the market is segregated into instruments and consumables & reagents. The instrument segment is further categorized into fluorescence-based droplet cell sorting, magnetic-activated cell sorting, and MEMS- Microfluidics. By application, the market is bifurcated into research applications and clinical applications. The research applications segment is further categorized into immunology & cancer research, stem cell research, drug discovery, and other research applications. By end user, the market is categorized into hospitals & clinical testing laboratories, pharmaceutical & biotechnology companies, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).

Major key players that operate in the cell sorter market are Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. Cytonome/St, LLC, Danaher Corporation, Harvard Bioscience, Inc., Miltenyi Biotec GmbH, On-Chip Biotechnologies Co., Ltd., Sony Corporation, Sysmex Corporation, and Thermo Fisher Scientific Inc. Key players have adopted product launch, partnership, and acquisition as key developmental strategies to improve the product portfolio of the cell sorter market.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell sorter market analysis from 2022 to 2032 to identify the prevailing cell sorter market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the cell sorter market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global cell sorter market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Criss-cross segment analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

• Instruments
  • Type
  • Fluorescence-based Droplet Cell Sorting
  • Magnetic-activated Cell Sorting
  • MEMS - Microfluidics
• Consumables and Reagents

By Application

• Research Application
  • Type
  • Immunology and Cancer Research
  • Stem Cell Research
  • Drug Discovery
  • Other Research Applications
• Clinical Applications

By End User

• Hospitals and Clinical Testing Laboratories
• Pharmaceutical and Biotechnology Companies
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Cytonome/St, LLC
• Danaher Corporation
• Harvard Bioscience, Inc.
• Miltenyi Biotec GmbH
• On-Chip Biotechnologies Co., Ltd.
• Sony Corporation
• Sysmex Corporation
• Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research Methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Moderate bargaining power of suppliers
  • 3.3.2. Moderate threat of new entrants
  • 3.3.3. Low threat of substitutes
  • 3.3.4. Moderate intensity of rivalry
  • 3.3.5. Low bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Rise in technological advancements in cell sorters
    • 3.4.1.2. Surge in government support for R&D activities
    • 3.4.1.3. Increase in prevalence of HIV and cancer
  • 3.4.2. Restraints
    • 3.4.2.1. High cost of cell sorters
  • 3.4.3. Opportunities
    • 3.4.3.1. Growth opportunities in emerging markets

CHAPTER 4: CELL SORTER MARKET, BY PRODUCT

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Instruments
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
  • 4.2.4. Instruments Cell Sorter Market by Type
• 4.3. Consumables and Reagents
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country

CHAPTER 5: CELL SORTER MARKET, BY APPLICATION

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Research Application
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
  • 5.2.4. Research Application Cell Sorter Market by Type
• 5.3. Clinical Applications
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country

CHAPTER 6: CELL SORTER MARKET, BY END USER

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Hospitals and Clinical Testing Laboratories
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Pharmaceutical and Biotechnology Companies
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Others
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country

CHAPTER 7: CELL SORTER MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by Product
  • 7.2.3. Market size and forecast, by Application
  • 7.2.4. Market size and forecast, by End User
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Market size and forecast, by Product
    • 7.2.5.1.2. Market size and forecast, by Application
    • 7.2.5.1.3. Market size and forecast, by End User
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Market size and forecast, by Product
    • 7.2.5.2.2. Market size and forecast, by Application
    • 7.2.5.2.3. Market size and forecast, by End User
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Market size and forecast, by Product
    • 7.2.5.3.2. Market size and forecast, by Application
    • 7.2.5.3.3. Market size and forecast, by End User
• 7.3. Europe
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by Product
  • 7.3.3. Market size and forecast, by Application
  • 7.3.4. Market size and forecast, by End User
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Market size and forecast, by Product
    • 7.3.5.1.2. Market size and forecast, by Application
    • 7.3.5.1.3. Market size and forecast, by End User
    • 7.3.5.2. France
    • 7.3.5.2.1. Market size and forecast, by Product
    • 7.3.5.2.2. Market size and forecast, by Application
    • 7.3.5.2.3. Market size and forecast, by End User
    • 7.3.5.3. UK
    • 7.3.5.3.1. Market size and forecast, by Product
    • 7.3.5.3.2. Market size and forecast, by Application
    • 7.3.5.3.3. Market size and forecast, by End User
    • 7.3.5.4. Italy
    • 7.3.5.4.1. Market size and forecast, by Product
    • 7.3.5.4.2. Market size and forecast, by Application
    • 7.3.5.4.3. Market size and forecast, by End User
    • 7.3.5.5. Spain
    • 7.3.5.5.1. Market size and forecast, by Product
    • 7.3.5.5.2. Market size and forecast, by Application
    • 7.3.5.5.3. Market size and forecast, by End User
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Market size and forecast, by Product
    • 7.3.5.6.2. Market size and forecast, by Application
    • 7.3.5.6.3. Market size and forecast, by End User
• 7.4. Asia-Pacific
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by Product
  • 7.4.3. Market size and forecast, by Application
  • 7.4.4. Market size and forecast, by End User
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. Japan
    • 7.4.5.1.1. Market size and forecast, by Product
    • 7.4.5.1.2. Market size and forecast, by Application
    • 7.4.5.1.3. Market size and forecast, by End User
    • 7.4.5.2. China
    • 7.4.5.2.1. Market size and forecast, by Product
    • 7.4.5.2.2. Market size and forecast, by Application
    • 7.4.5.2.3. Market size and forecast, by End User
    • 7.4.5.3. Australia
    • 7.4.5.3.1. Market size and forecast, by Product
    • 7.4.5.3.2. Market size and forecast, by Application
    • 7.4.5.3.3. Market size and forecast, by End User
    • 7.4.5.4. India
    • 7.4.5.4.1. Market size and forecast, by Product
    • 7.4.5.4.2. Market size and forecast, by Application
    • 7.4.5.4.3. Market size and forecast, by End User
    • 7.4.5.5. South Korea
    • 7.4.5.5.1. Market size and forecast, by Product
    • 7.4.5.5.2. Market size and forecast, by Application
    • 7.4.5.5.3. Market size and forecast, by End User
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Market size and forecast, by Product
    • 7.4.5.6.2. Market size and forecast, by Application
    • 7.4.5.6.3. Market size and forecast, by End User
• 7.5. LAMEA
  • 7.5.1. Key market trends, growth factors and opportunities
  • 7.5.2. Market size and forecast, by Product
  • 7.5.3. Market size and forecast, by Application
  • 7.5.4. Market size and forecast, by End User
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Market size and forecast, by Product
    • 7.5.5.1.2. Market size and forecast, by Application
    • 7.5.5.1.3. Market size and forecast, by End User
    • 7.5.5.2. Saudi Arabia
    • 7.5.5.2.1. Market size and forecast, by Product
    • 7.5.5.2.2. Market size and forecast, by Application
    • 7.5.5.2.3. Market size and forecast, by End User
    • 7.5.5.3. South Africa
    • 7.5.5.3.1. Market size and forecast, by Product
    • 7.5.5.3.2. Market size and forecast, by Application
    • 7.5.5.3.3. Market size and forecast, by End User
    • 7.5.5.4. Rest of LAMEA
    • 7.5.5.4.1. Market size and forecast, by Product
    • 7.5.5.4.2. Market size and forecast, by Application
    • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

• 9.1. Becton, Dickinson and Company
  • 9.1.1. Company overview
  • 9.1.2. Key Executives
  • 9.1.3. Company snapshot
  • 9.1.4. Operating business segments
  • 9.1.5. Product portfolio
  • 9.1.6. Business performance
  • 9.1.7. Key strategic moves and developments
• 9.2. Bio-Rad Laboratories, Inc.
  • 9.2.1. Company overview
  • 9.2.2. Key Executives
  • 9.2.3. Company snapshot
  • 9.2.4. Operating business segments
  • 9.2.5. Product portfolio
  • 9.2.6. Business performance
  • 9.2.7. Key strategic moves and developments
• 9.3. Cytonome/St, LLC
  • 9.3.1. Company overview
  • 9.3.2. Key Executives
  • 9.3.3. Company snapshot
  • 9.3.4. Operating business segments
  • 9.3.5. Product portfolio
• 9.4. Danaher Corporation
  • 9.4.1. Company overview
  • 9.4.2. Key Executives
  • 9.4.3. Company snapshot
  • 9.4.4. Operating business segments
  • 9.4.5. Product portfolio
  • 9.4.6. Business performance
• 9.5. Harvard Bioscience, Inc.
  • 9.5.1. Company overview
  • 9.5.2. Key Executives
  • 9.5.3. Company snapshot
  • 9.5.4. Operating business segments
  • 9.5.5. Product portfolio
  • 9.5.6. Business performance
• 9.6. Miltenyi Biotec GmbH
  • 9.6.1. Company overview
  • 9.6.2. Key Executives
  • 9.6.3. Company snapshot
  • 9.6.4. Operating business segments
  • 9.6.5. Product portfolio
• 9.7. On-Chip Biotechnologies Co., Ltd.
  • 9.7.1. Company overview
  • 9.7.2. Key Executives
  • 9.7.3. Company snapshot
  • 9.7.4. Operating business segments
  • 9.7.5. Product portfolio
  • 9.7.6. Key strategic moves and developments
• 9.8. Thermo Fisher Scientific Inc.
  • 9.8.1. Company overview
  • 9.8.2. Key Executives
  • 9.8.3. Company snapshot
  • 9.8.4. Operating business segments
  • 9.8.5. Product portfolio
  • 9.8.6. Business performance
  • 9.8.7. Key strategic moves and developments
• 9.9. Sony Corporation
  • 9.9.1. Company overview
  • 9.9.2. Key Executives
  • 9.9.3. Company snapshot
  • 9.9.4. Operating business segments
  • 9.9.5. Product portfolio
  • 9.9.6. Business performance
• 9.10. Sysmex Corporation
  • 9.10.1. Company overview
  • 9.10.2. Key Executives
  • 9.10.3. Company snapshot
  • 9.10.4. Operating business segments
  • 9.10.5. Product portfolio
  • 9.10.6. Business performance